Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Eric Lindberg shares his story.
Dr. Jason Sicklick of Moores Cancer Center at the University of California San Diego talks about the Phase II study of Temozolomide (TMZ) in advanced SDH-mutant/deficient GIST, a new study available to patients with SDH-deficient GIST.
Kathy Sarmiento presents, The A B C’s of Medicare: Everything you need to know. Kathy explains everything from medicare costs and eligibility, to finding the right path for you.
Patient Support Group meeting on GIST Awareness Day in Mumbai, India, 2019.
Blueprint Medicines hosted a webinar for the GIST patient and caregiver community about Avapritinib, an investigational medicine for people with advanced GIST.